Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maintenance pemetrexed vs pemetrexed at progression in advanced NSCLC
2013-001237-41Phase 3Completed
- Sponsor
- Norwegian University of Science and Technology
- Start
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pemetrexed in non-small cell lung cancer (NSCLC), sponsored by Norwegian University of Science and Technology. Started Apr 2013; status: completed.
02
Drugs
pemetrexed
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on 2013-001237-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001237-41.